Lineage Cell Therapeutics Announces Issuance of US Patent for System for Generating Immunogenic Dendritic Cells  BioSpace

CARLSBAD, Calif.–(BUSINESS WIRE)– Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company …